Evidence map›Paper›PMID 41821881›Full record

ArticleFrontiers in oncology2026

Impact of nutritional source modality on weight loss and BMI reduction after hematopoietic stem cell transplantation.

Francesco Paolo Tambaro, Francesco Fabozzi, Riccardo Masetti, Fabiana Cacace, Gennaro Pagano, Francesco Cecere, Valeria Caprioli, Giuseppina De Simone, Maria Rosaria D'Amico, Emanuela Rossitti and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Francesco Paolo TambaroPediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Francesco FabozziPediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Riccardo MasettiPediatric Hematology and Oncology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Fabiana CacacePediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Gennaro PaganoPediatric Hematology and Oncology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Francesco CecereUnità Operativa Semplice (UOS) Laboratori di Ricerca e Biobanca, UOC Ricerca Clinica e Traslazionale, AORN Santobono Pausilipon, Napoli, Italy.
Valeria CaprioliPediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Giuseppina De SimonePediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Maria Rosaria D'AmicoPediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Emanuela RossittiPediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Edoardo MuratorePediatric Hematology and Oncology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Davide LeardiniPediatric Hematology and Oncology, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Maria Simona SabbatinoPediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Deterioration of nutritional status in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients is associated with increased morbidity. Enteral nutrition (EN) has been associated with more favorable outcomes than total parenteral nutrition (TPN); however, TPN remains the first-line nutritional source in many pediatric transplant centers because of health providers and caregiver limitations and biases. Oral nutritional (ON) source may help overcome these limitations, but evidence supporting efficacy in allo-HSCT recipients is currently lacking. We retrospectively evaluated the impact of three nutritional source modalities (ON, EN, and parenteral nutrition) on nutritional status in 125 children undergoing allo-HSCT in two Italian pediatric centers. Secondary endpoints included associations between nutrition modality and several allo-HSCT outcomes: time to engraftment, length of hospitalization, and incidence of acute graft-versus-host disease (aGvHD). A total of 41 patients received TPN, 47/125 received ON, and 37/125 received EN. Patients supported by EN experienced a significantly lower body mass index (BMI) decrease compared to others (-0.45; range -2.18 to 3.95; IQR -0.67 to -0.15 kg/m

Indexed as

enteral nutritionnutritional supportoral nutritionparenteral nutritionpediatric allogeneic hematopoietic stem cell transplantation

Identifiers

PMID41821881
PMCPMC12975454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.